Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: CVRx, Inc.

Market Cap 130M 113M 104M 97.26M 182M 12.42B 186M 1.24B 479M 5.99B 487M 477M 20.82B P/E Ratio 2026 *
-2.49x
P/E Ratio 2027 * -2.58x
Enterprise Value 155M 135M 124M 116M 217M 14.87B 222M 1.48B 574M 7.17B 583M 570M 24.92B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.6x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day+1.24%
1 week-16.84%
Current month-12.37%
1 month-29.34%
3 months-37.55%
6 months-41.92%
Current year-31.13%
1 week 4.77
Extreme 4.77
5.56
1 month 4.77
Extreme 4.77
6.43
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 2024-02-11
Director of Finance/CFO 43 2020-09-30
Chief Operating Officer - 2022-01-31
Director TitleAgeSince
Director/Board Member 61 2008-09-30
Director/Board Member 57 2020-06-30
Director/Board Member 52 2020-06-30
Date Insider Type Main position Quantity % Market Cap.
05-31
Treo Ventures LLC
OtherCompany 0 0%
05-31Free

Director

65,257 0.2459%
05-31Free

Director

19,902 0.0750%
Change 5-day change 1-year change 3-year change Capi.($)
+1.24%-16.84%-26.02%-66.98% 130M
-0.32%-0.72%+25.66%-1.48% 12.52B
-4.84%-3.63%+51.96%+31.80% 6.32B
+3.57%+0.44%+3.97%-20.97% 5.38B
+5.17%+10.03% - - 4.34B
+2.70%+0.32%-28.98%+17.92% 4.16B
-0.51%-2.39%-31.01%-22.90% 3.73B
+6.37%-1.56%+2.02%-58.58% 2.05B
+1.44%+0.18%+37.41%+184.70% 1.65B
-2.11%-1.15%+56.79%-0.82% 1.59B
Average +1.28%-1.35%+10.20%+6.96% 4.19B
Weighted average by Cap. +0.69%+0.28%+15.66%+6.19%

Financials

2026 *2027 *
Net sales 65.28M 56.65M 52.22M 48.93M 91.43M 6.25B 93.33M 623M 241M 3.01B 245M 240M 10.48B 76.18M 66.11M 60.94M 57.1M 107M 7.29B 109M 727M 281M 3.52B 286M 280M 12.22B
Net income -52.82M -45.84M -42.25M -39.59M -73.97M -5.06B -75.51M -504M -195M -2.44B -198M -194M -8.48B -52.14M -45.25M -41.71M -39.08M -73.02M -4.99B -74.54M -498M -193M -2.41B -196M -192M -8.37B
Net Debt 25.51M 22.14M 20.41M 19.12M 35.73M 2.44B 36.47M 243M 94.25M 1.18B 95.77M 93.71M 4.09B 68.44M 59.39M 54.75M 51.3M 95.84M 6.55B 97.84M 653M 253M 3.16B 257M 251M 10.98B
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
26-06-11 4.890 $ +1.24% 474,970
26-06-10 4.830 $ -7.12% 445,528
26-06-09 5.200 $ -3.70% 401,654
26-06-08 5.400 $ +0.37% 242,040
26-06-05 5.380 $ -8.50% 234,821
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
4.890USD
Average target price
11.17USD
Spread / Average Target
+128.36%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!